1832 Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$173M Buy
1,994,211
+454,906
+30% +$43.6M 0.16% 108
2025
Q4
$148M Sell
1,539,305
-230,295
-13% -$22.4M 0.11% 127
2025
Q3
$169M Sell
1,769,600
-115,086
-6% -$10.6M 0.13% 90
2025
Q2
$164M Buy
1,884,686
+24,839
+1% +$2.11M 0.13% 92
2025
Q1
$167M Sell
1,859,847
-1,504,293
-45% -$135M 0.15% 88
2024
Q4
$269M Buy
3,364,140
+267,011
+9% +$23.1M 0.23% 53
2024
Q3
$279M Sell
3,097,129
-1,818,480
-37% -$153M 0.21% 53
2024
Q2
$387M Buy
4,915,609
+1,041,863
+27% +$85.4M 0.31% 39
2024
Q1
$338M Buy
3,873,746
+820,175
+27% +$70M 0.2% 42
2023
Q4
$252M Buy
3,053,571
+744,968
+32% +$56.8M 0.36% 56
2023
Q3
$181M Buy
2,308,603
+603,841
+35% +$50.5M 0.26% 69
2023
Q2
$150M Buy
1,704,762
+155,408
+10% +$13.4M 0.18% 79
2023
Q1
$125M Buy
1,549,354
+15,884
+1% +$1.29M 0.18% 84
2022
Q4
$119M Sell
1,533,470
-168,687
-10% -$13.7M 0.2% 96
2022
Q3
$137M Sell
1,702,157
-629,664
-27% -$56.6M 0.26% 78
2022
Q2
$209M Sell
2,331,821
-1,688,639
-42% -$171M 0.37% 63
2022
Q1
$440M Buy
4,020,460
+204,457
+5% +$21.6M 0.63% 43
2021
Q4
$403M Sell
3,816,003
-68,811
-2% -$7.97M 0.71% 46
2021
Q3
$494M Sell
3,884,814
-59,991
-2% -$7.76M 0.93% 31
2021
Q2
$490M Sell
3,944,805
-233,497
-6% -$29.3M 0.95% 26
2021
Q1
$498M Buy
4,178,302
+92,411
+2% +$10.8M 1.08% 18
2020
Q4
$474M Sell
4,085,891
-243,898
-6% -$26.8M 1.11% 20
2020
Q3
$447M Buy
4,329,789
+650,944
+18% +$65.4M 1.17% 19
2020
Q2
$335M Buy
3,678,845
+285,870
+8% +$27.4M 1% 21
2020
Q1
$314M Buy
3,392,975
+438,627
+15% +$46.7M 1.13% 20
2019
Q4
$335M Sell
2,954,348
-1,133
-0% -$124K 1.02% 27
2019
Q3
$317M Sell
2,955,481
-682,953
-19% -$71.3M 1.01% 27
2019
Q2
$355M Buy
3,638,434
+126,370
+4% +$11.5M 1.15% 24
2019
Q1
$317M Buy
3,512,064
+235,786
+7% +$21.1M 1.08% 27
2018
Q4
$298M Buy
3,276,278
+11,750
+0.4% +$1.1M 1.18% 24
2018
Q3
$321M Sell
3,264,528
-295,639
-8% -$27.3M 1.05% 29
2018
Q2
$305M Sell
3,560,167
-911,396
-20% -$76.1M 1.03% 31
2018
Q1
$360M Buy
4,471,563
+222,752
+5% +$18.4M 1.33% 19
2017
Q4
$341M Buy
4,248,811
+821,666
+24% +$65.8M 1.11% 27
2017
Q3
$258M Buy
3,427,145
+808,264
+31% +$67.1M 0.9% 34
2017
Q2
$233M Sell
2,618,881
-1,914
-0.1% -$161K 1.05% 25
2017
Q1
$212M Sell
2,620,795
-1,032,649
-28% -$80.7M 0.76% 38
2016
Q4
$286M Buy
3,653,444
+1,554,573
+74% +$122M 0.48% 54
2016
Q3
$181M Sell
2,098,871
-1,046,540
-33% -$91.2M 0.68% 38
2016
Q2
$274M Sell
3,145,411
-178,175
-5% -$14.4M 1.07% 27
2016
Q1
$421M Buy
3,323,586
+10,772
+0.3% +$811K 1.02% 29
2015
Q4
$257M Sell
3,312,814
-2,593,415
-44% -$195M 1.11% 23
2015
Q3
$396M Sell
5,906,229
-7,175
-0.1% -$528K 1.66% 11
2015
Q2
$437M Buy
5,913,404
+971,884
+20% +$74.3M 1.48% 14
2015
Q1
$385M Buy
4,941,520
+1,870,970
+61% +$142M 1.45% 18
2014
Q4
$221M Buy
3,070,550
+192,968
+7% +$13.4M 0.68% 37
2014
Q3
$178M Buy
2,877,582
+949,415
+49% +$60.4M 0.58% 43
2014
Q2
$123M Buy
1,928,167
+1,253,530
+186% +$76.1M 0.39% 66
2014
Q1
$40.8M Sell
674,637
-1,216,930
-64% -$70.9M 0.14% 153
2013
Q4
$109M Buy
1,891,567
+954,977
+102% +$54.1M 0.42% 62
2013
Q3
$49.8M Sell
936,590
-877,417
-48% -$47.2M 0.22% 114
2013
Q2
$93.3M Buy
+1,814,007
New +$89.7M 0.41% 67

Other funds holding MDT

1832 Asset Management's MDT Position: Q1 2026 in Review

1832 Asset Management increased its Medtronic (MDT) stake by 30% in Q1 2026, buying an estimated $43.6M and bringing the position to 1,994,211 shares worth $173M. The position accounts for 0.16% of the portfolio, ranked #108.

1832 Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $498M in Q1 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • 1832 Asset Management held 1,994,211 shares of Medtronic worth $173M as of Q1 2026.
  • 1832 Asset Management bought 454,906 Medtronic shares in Q1 2026, an estimated $43.6M.
  • Medtronic made up 0.16% of 1832 Asset Management's portfolio in Q1 2026, its #108 holding.
  • 1832 Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • 1832 Asset Management's Medtronic position peaked at $498M in Q1 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.